Cite this article
Volume | Year
European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Comparison of Pelvic Masses Score (PMS) and Risk of Malignancy Index (RMI 3) in the evaluation of pelvic masse
A. Rossi1, L. Forzano1, I. Romanello1,*, G. Ambrosini2, V. Iuri1, D. Marchesoni1
1 Department of Obstetrics and Gynecology, University of Udine, Udine
2 Department of Obstetrics and Gynecology, University of Padua, Padua (Italy)
Eur. J. Gynaecol. Oncol. 2014, 35(4), 421–424; https://doi.org/10.12892/ejgo24562014
Published: 10 August 2014
Purpose: Ovarian cancer is the fourth cause of death from cancer in women worldwide and the majority of its diagnoses is made in an advanced stage of the disease. Several sonographic scoring systems have been created for a better preoperative discrimination between benign and malignant pelvic masses. The aim of this study was to evaluate the performances of the Risk of the Malignancy Index 3 (RMI 3) and the Pelvic Masses Score (PMS). Materials and Methods: This retrospective study was performed in 55 women admitted to the department of Obstetrics and Gynecology of University of Udine for surgical exploration of pelvic masses between 2009 and 2012. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated for both the scores. Results: PMS showed a sensitivity of 100%, a specificity of 93.8%, a PPV of 70%, and a NPV of 100%, while RMI 3 yielded a sensitivity of 85%, a specificity of 91%, a PPV of 60%, and a NPV of 97.8%. Conclusion: The authors found that, in discriminating between benign and malignant pelvic disease, the PMS method was more reliable than RMI3. PMS is a simple scoring system which can be used in clinical practice.
Risk of malignancy index
Pelvic masses score